Problem recognition, intention to stop use, and treatment use among regular heroin injectors.

Authors:
Address:
Journal:

Publication:

abstract

This study investigated frequency of recent use as an explanatory variable in Problem recognition and intention to stop use among regular injection heroin users. Data from the NEURO-HIV Epidemiologic Study, an investigation of neuropsychological and social-behavioral risk factors for HIV and hepatitis A, B, and C among injection and noninjection drug users, were used in the analyses. Participants (N = 337) consisted of those who reported injecting heroin daily or nearly daily for a period of 3 months. Multiple linear regression analysis revealed that frequency of recent injection drug use predicted problem recognition (β = .17), but not intention to stop use; although marginal, being female (β = .15), and homeless (β = .14) contributed to intention to stop use. Past 6-month treatment participation was 48%, and current treatment enrollment was 26% among study participants. This study highlights the importance of capitalizing on injection drug users' recent use as a mechanism for treatment interventions.

Related Articles
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Addiction. 2007
The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, Mcknight C, Bramson H, Friedman SR. Addiction. 2007 May; 102(5):778-85.
Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal.
Can J Public Health. 2006
Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal.
De P, Jolly A, Cox J, Boivin JF. Can J Public Health. 2006 May-Jun; 97(3):207-9.
Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
J Acquir Immune Defic Syndr. 2...
Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
De P, Cox J, Boivin JF, Platt RW, Jolly AM. J Acquir Immune Defic Syndr. 2007 Nov 1; 46(3):355-61.
The characteristics of 'new users' of cocaine and heroin unknown to treatment agencies: results from the Swiss Hidden Population Study.
Addiction. 2000
The characteristics of 'new users' of cocaine and heroin unknown to treatment agencies: results from the Swiss Hidden Population Study.
Kuebler D, Hausser D, Gervasoni JP. Addiction. 2000 Oct; 95(10):1561-71.
Review Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.
Public Health Rep. 2002
Review Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.
Estrada AL. Public Health Rep. 2002; 117 Suppl 1:S126-34.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.